Transmission of human immunodeficiency virus type 1 through breastfeeding: How can it be prevented?

Journal of Infectious Diseases

Volumn 179, Issue SUPPL. 3, 1999, Pages

  Van De Perre, Philippe ^a  

^a CENTRE MURAZ   (Burkina Faso)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; LACTOFERRIN; RETINOL; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; ZIDOVUDINE;

ARTIFICIAL MILK; BREAST FEEDING; BREAST MILK; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONFERENCE PAPER; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL TRACT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT MORTALITY; LACTATION; PREGNANCY; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSMISSION;

ADULT; BREAST FEEDING; BURKINA FASO; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MILK, HUMAN; MOUTH MUCOSA; TIME FACTORS;

EID: 0032953964     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314793     Document Type: Conference Paper

References (17)

1. 1. Dabis F, Msellati P, Dunn D, et al. Estimating the rate of mother-to-child transmission of HIV. Report of a workshop on methodological issues, Ghent, Belgium, 17-20 February 1992. AIDS 1993; 7:1139-48.
2. 2. Rouzioux C, Costagoliola D, Burgard M, et al. Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. Am J Epidemiol 1995; 142:1330-7.
3. 3. Simonon A, Lepage P, Karita E, et al. An assessment of the timing of mother-to-child transmission of human immunodeficiency virus type 1 by means of polymerase chain reaction. J Acquir Immune Defic Syndr 1994; 7:952-7.
4. 4. Dunn DT, Newell ML, Ades AE, Peckham C. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 1992; 340: 585-8.
5. 5. Van de Perre P. Postnatal transmission of the human immunodeficiency virus type 1 and the breastfeeding dilemma. Am J Obstet Gynecol 1995; 173: 483-7.
6. 6. Oxtoby MJ. Human immunodeficiency virus and other viruses in human milk: placing the issue in broader perspective. Pediatr Infect Dis J 1988; 7: 825-35.
7. 7. Van de Perre P, Simonon A, Hitimana DG, et al. Infective and anti-infective properties of breast milk from HIV-1-infected women. Lancet 1993; 341: 914-8.
8. 8. Nduati RW, John GC, Richardson BA, et al. Human immunodeficiency virus type 1 infected cells in breast milk: association with immunosuppression and vitamin A deficiency. J Infect Dis 1995; 172:1461-8.
9. 9. Lewis P, Nduati R, Kreiss JK, et al. Cell-free human immunodeficiency virus type 1 in breast milk. J Infect Dis 1998; 177:34-9.
10. 10. Toniolo A, Serra C, Conaldi PG, Basolo F, Falcone V, Dolei A. Productive HIV-1 infection of normal human mammary epithelial cells. AIDS 1995; 9: 859-66.
11. 11. Southern S, Southern PJ. Oral transmission of HIV-1 during long-term breastfeeding [abstract 8]. In: Proceedings of the Conference on HIV-1 and Mucosal Pathogenesis (NIH, Bethesda MD; 11-13 September 1997). NIH, 1997.
12. 12. Semba RD, Miotti PG, Chiphangwi JD, et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994; 343:1593-7.
13. 13. Harmsen MC, Swart PJ, de Bethune MP, et al. Antiviral effect of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and cytomegalovirus replication in vitro. J Infect Dis 1995; 172:380-8.
14. 14. Wahl SM, McNeely TB, Janoff EN, et al. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-1. Oral Dis 1997; 3(Suppl 1):S64-9.
15. 15. Janoff EN, Eidman K, McNeely TB, et al. Secretory leukocyte protease inhibitor (SLPI), an HIV-1 inhibitory protein and rates of HIV-1 transmission by mucosal fluids [abstract 2]. In: Proceedings of the Conference on HIV-1 and Mucosal Pathogenesis (NIH, Bethesda MD; 11-13 September 1997). NIH, 1997.
16. 16. Van de Perre P, Meda N, Cartoux M, et al. Zidovudine and breastfeeding. AIDS Patient Care STD 1997; 11:4-5.
17. 17. de Jong MD, de Boer RJ, de Wolf F, et al. Transient overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment: role of target cell availability. AIDS 1997; 11:F79-84.